Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Freeport-McMoRan Inc. (FCX) Surges As Carl Icahn Receives Two Board Seats

Page 1 of 2

Even though Carl Icahn emphasized that the U.S stock markets are overvalued in a recent video released on his website, he keeps buying more shares of seemingly undervalued companies. Just a few weeks ago, he disclosed an ownership stake of exactly 100 million shares in Freeport-McMoRan Inc. (NYSE:FCX) via an amended 13D filing, which accounts for 8.80% of the company’s outstanding shares. Earlier this morning, the company’s officials and Icahn announced an agreement has been reached between them, under which two of Icahn’s representatives have been appointed to Freeport-McMoRan’s Board of Directors. Shares of Freeport-McMoRan have gained just under 10% in trading today on the news.

Hedge Fund Strategies

It is unbelievable in one sense how the market reacts to Icahn’s every move, though not when we consider his track record of helping companies and unlocking shareholder value. The American billionaire investor is widely-known as one of the greatest activist investors in history, and has shaken up numerous companies throughout his investment career. Most importantly, Icahn does not seek to generate short-term gains from his activist campaigns, as some of his peers, but focuses instead on fixing companies for a profitable longer-term spectrum. Just recently, he reported lifting his stake in Cheniere Energy Inc. (NYSEMKT:LNG) to 28.8 million shares or 12.07% (read more details here). As stated by Icahn’s 13F filing for the June quarter, Icahn Capital LP manages an equity portfolio with a market value of $31.20 billion.

Carl Icahn
Carl Icahn
Icahn Capital LP

Hedge funds and other big money managers like Icahn tend to have the largest amounts of their capital invested in large and mega-cap stocks like Apple Inc. (NASDAQ:AAPL) because these companies allow for much greater capital allocation. That’s why if we take a look at the most popular stocks among funds, we won’t find any mid- or small-cap stocks there. However, our backtests of hedge funds’ equity portfolios between 1999 and 2012 revealed that the 50 most popular stocks among hedge funds underperformed the market by seven basis points per month, showing that their most popular picks and the ones that received the bulk of their capital were not actually their best picks. On the other hand, their top small-cap picks performed considerably better, outperforming the market by 95 basis points per month. This was confirmed through backtesting and in forward tests of our small-cap strategy since August 2012. The strategy, which involves imitating the 15 most popular small-cap picks among hedge funds has provided gains of 118%, beating the broader market by 60 percentage points over the past 36 months (see the details).

Freeport-McMoRan Inc. (NYSE:FCX) received extra attention from the hedge fund industry during the second quarter, as the number of top money managers invested in the stock increased to 41 from 31 quarter-over-quarter. At the same time, the value of their holdings more than doubled during this time span, increasing to $581.83 million from $258.10 million. Nonetheless, it is also worth mentioning that the hedge funds tracked by Insider Monkey collectively owned just 3.00% of the company’s outstanding shares on June 30, though this figure is much greater now following Icahn’s large purchase. Meanwhile, Stanley Druckenmiller’s Duquesne Capital added a 3.55 million-share position in Freeport-McMoRan during the second quarter, making it one of the largest shareholders of the company within our database.

Follow Freeport-Mcmoran Inc (NYSE:FCX)
Trade (NYSE:FCX) Now!
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!